Tags

Type your tag names separated by a space and hit enter

Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.
Patient Prefer Adherence. 2020; 14:1037-1047.PP

Abstract

Purpose

Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by chronic destructive synovitis and possible multisystem involvement. This study aimed to survey the treatment satisfaction of physicians and patients with RA, and to explore the potential factors.

Patients and Methods

This cross-sectional study was conducted in 12 centers across China between March 2018 and April 2018. The Treatment Satisfaction Questionnaire for Medication version II was used to assess the treatment satisfaction of patients and physicians. Multivariable regression analysis was used to determine the factors independently associated with treatment satisfaction of patients.

Results

The patients' satisfaction (n=335) with biological disease-modifying antirheumatic drugs (bDMARDs) was higher than physicians' satisfaction (n=146) regarding the side effects (95.0±14.3 vs 84.6±15.7, P<0.001) and convenience (74.6±21.2 vs 69.1±16.5, P=0.002). Among physicians, global satisfaction with bDMARDs was higher than that with conventional synthetic DMARDs (csDMARDs). The multivariable regression analysis showed that age was positively associated with satisfaction of patients, while college or above education and self-assessment of disease severity were inversely associated with satisfaction. Treatment satisfaction was associated positively with the quality of communication with the physician and inversely with treatment costs.

Conclusion

For bDMARDs, the treatment satisfaction of patients with RA is generally higher than that of physicians'. Physicians' satisfaction with bDMARDs is higher than with csDMARDs. Age, education, disease severity, communication with the physician, and treatment costs are independently associated with the treatment satisfaction among patients. Physician-patient communication should be improved in clinical practice. Treatment costs should be taken into account when physicians make decisions.

Authors+Show Affiliations

Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China.Department of Rheumatology and Immunology, First Affiliated Hospital, China Medical University, Shenyang, People's Republic of China.Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.Department of Rheumatology, Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia, People's Republic of China.Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang Uygur Autonomous Region, People's Republic of China.Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan, People's Republic of China.Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing, People's Republic of China.Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin, People's Republic of China.Department of Clinical Immunology and Rheumatology, Xijing Hospital Affiliated to the Fourth Military Medical University, Shanxi, People's Republic of China.Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China.Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China.Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China.Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32606620

Citation

Jiang, Nan, et al. "Satisfaction of Patients and Physicians With Treatments for Rheumatoid Arthritis: a Population-Based Survey in China." Patient Preference and Adherence, vol. 14, 2020, pp. 1037-1047.
Jiang N, Yang P, Liu S, et al. Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China. Patient Prefer Adherence. 2020;14:1037-1047.
Jiang, N., Yang, P., Liu, S., Li, H., Wu, L., Shi, X., Fang, Y., Zhao, Y., Xu, J., Jiang, Z., Wu, Z., Duan, X., Wang, Q., Tian, X., Li, M., & Zeng, X. (2020). Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China. Patient Preference and Adherence, 14, 1037-1047. https://doi.org/10.2147/PPA.S232578
Jiang N, et al. Satisfaction of Patients and Physicians With Treatments for Rheumatoid Arthritis: a Population-Based Survey in China. Patient Prefer Adherence. 2020;14:1037-1047. PubMed PMID: 32606620.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China. AU - Jiang,Nan, AU - Yang,Pingting, AU - Liu,Shengyun, AU - Li,Hongbin, AU - Wu,Lijun, AU - Shi,Xiaofei, AU - Fang,Yongfei, AU - Zhao,Yi, AU - Xu,Jian, AU - Jiang,Zhenyu, AU - Wu,Zhenbiao, AU - Duan,Xinwang, AU - Wang,Qian, AU - Tian,Xinping, AU - Li,Mengtao, AU - Zeng,Xiaofeng, Y1 - 2020/06/23/ PY - 2019/09/26/received PY - 2020/03/14/accepted PY - 2020/7/2/entrez PY - 2020/7/2/pubmed PY - 2020/7/2/medline KW - TSQM-II KW - patient KW - physician KW - rheumatoid arthritis KW - treatment satisfaction SP - 1037 EP - 1047 JF - Patient preference and adherence JO - Patient Prefer Adherence VL - 14 N2 - Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by chronic destructive synovitis and possible multisystem involvement. This study aimed to survey the treatment satisfaction of physicians and patients with RA, and to explore the potential factors. Patients and Methods: This cross-sectional study was conducted in 12 centers across China between March 2018 and April 2018. The Treatment Satisfaction Questionnaire for Medication version II was used to assess the treatment satisfaction of patients and physicians. Multivariable regression analysis was used to determine the factors independently associated with treatment satisfaction of patients. Results: The patients' satisfaction (n=335) with biological disease-modifying antirheumatic drugs (bDMARDs) was higher than physicians' satisfaction (n=146) regarding the side effects (95.0±14.3 vs 84.6±15.7, P<0.001) and convenience (74.6±21.2 vs 69.1±16.5, P=0.002). Among physicians, global satisfaction with bDMARDs was higher than that with conventional synthetic DMARDs (csDMARDs). The multivariable regression analysis showed that age was positively associated with satisfaction of patients, while college or above education and self-assessment of disease severity were inversely associated with satisfaction. Treatment satisfaction was associated positively with the quality of communication with the physician and inversely with treatment costs. Conclusion: For bDMARDs, the treatment satisfaction of patients with RA is generally higher than that of physicians'. Physicians' satisfaction with bDMARDs is higher than with csDMARDs. Age, education, disease severity, communication with the physician, and treatment costs are independently associated with the treatment satisfaction among patients. Physician-patient communication should be improved in clinical practice. Treatment costs should be taken into account when physicians make decisions. SN - 1177-889X UR - https://www.unboundmedicine.com/medline/citation/32606620/Satisfaction_of_Patients_and_Physicians_with_Treatments_for_Rheumatoid_Arthritis:_A_Population-Based_Survey_in_China L2 - https://dx.doi.org/10.2147/PPA.S232578 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.